The term “off-label” refers to the use of a medication for a purpose that is not specifically approved by regulators, like the U.S. Food and Drug Administration, but is based on the prescriber’s professional judgment...
A wise man once said, “How you do anything is how you do everything.” In that vein, the time to begin preparing for the potential sale of a DMEPOS provider’s business down the road begins well before the first claim for...
Insurance companies engage a network of providers and health care facilities that agree to go “in network”, or accept a specific payment amount for their services. If a provider or facility isn’t “in network,” they...